Preferences and Perspectives of Specialist Multiple Sclerosis Nurses and Patients with Multiple Sclerosis Regarding the New RebiSmart® 3.0 Autoinjector versus Other Assistive Devices

Preferences and Perspectives of Specialist Multiple Sclerosis Nurses and Patients with Multiple Sclerosis Regarding the New RebiSmart® 3.0 Autoinjector versus Other Assistive Devices

Sridevi S Colten,1 Elisabetta Verdun di Cantogno,2 Dominic Jack3 1Department of MS Market Research & Analysis, EMD Serono Research and Development Institute, Inc. (an Affiliate of Merck KGaA), Billerica, MA, USA; 2Department of MS Medical Affairs, EMD Serono Research and Development Institute, I...

Full description

Bibliographic Details
Main Authors:	Colten SS, di Cantogno EV, Jack D
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-02-01
Series:	Medical Devices: Evidence and Research
Subjects:	subcutaneous interferon beta-1a customizable injection hidden needle neurodegenerative disorder nurse and patient device assessment online survey
Online Access:	https://www.dovepress.com/preferences-and-perspectives-of-specialist-multiple-sclerosis-nurses-a-peer-reviewed-fulltext-article-MDER

Similar Items

Evolution of the RebiSmart® Electromechanical Autoinjector to Improve Usability in Support of Adherence to Subcutaneous Interferon Beta-1a Therapy for People Living with Multiple Sclerosis
by: Lin YT, et al.
Published: (2023-08-01)

Subjective patient-reported versus objective adherence to subcutaneous interferon β-1a in multiple sclerosis using RebiSmart®: the CORE study
by: Chiara Zecca, et al.
Published: (2017-09-01)

Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart® injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis
by: Krol M, et al.
Published: (2017-07-01)

Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart® in patients with multiple sclerosis
by: Edo Solsona MD, et al.
Published: (2017-03-01)

Seasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study
by: Spyros N. Deftereos, et al.
Published: (2018-11-01)

Long-Term Adherence to IFN Beta-1a Treatment when Using RebiSmart® Device in Patients with Relapsing-Remitting Multiple Sclerosis.
by: O Fernández, et al.
Published: (2016-01-01)

MetaLIMS, a simple open-source laboratory information management system for small metagenomic labs
by: Heinle, Cassie Elizabeth, et al.
Published: (2017)

Predictors of Adherence Among Patients With Multiple Sclerosis Using the BETACONNECT® Autoinjector: A Prospective Observational Cohort Study
by: Wolfgang Köhler, et al.
Published: (2021-02-01)

An observational, retrospective, UK and Ireland audit of patient adherence to subcutaneous interferon beta-1a injections using the RebiSmart® injection device
by: Willis H, et al.
Published: (2014-06-01)

Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives
by: Mark S. Freedman, et al.
Published: (2024-01-01)

Adherence, satisfaction and functional health status among patients with multiple sclerosis using the BETACONNECT® autoinjector: a prospective observational cohort study
by: Ingo Kleiter, et al.
Published: (2017-09-01)

Design of a Customizable Preview Feature on Clothing Website
by: Eddy Soeryanto Soegoto, et al.
Published: (2022-01-01)

PRINCIPLES OF THE SYSTEM OF "CUSTOMIZABLE” DEFENSE ON THE FULL BASKETBALL COURT
by: Pavle Rubin
Published: (2010-09-01)

Association of Multiple Sclerosis and Uveitis
by: Cansu Söylemez, et al.
Published: (2018-03-01)

Multiple sclerosis: evidence and controversies
by: Ángela María Gutiérrez-Álvarez
Published: (2006-06-01)

Adherence to subcutaneous interferon beta-1a treatment among patients with relapsing multiple sclerosis: the MAIN-MS study
by: Raed Al-Roughani, et al.
Published: (2023-11-01)

Sleep Quality in Patients with Multiple Sclerosis
by: Arash Mosarrezaii, et al.
Published: (2019-01-01)

Co-occurrence of multiple sclerosis and Parkinson disease
by: Vahid Shaygannejad, et al.
Published: (2016-01-01)

[Pegylation and interferons in multiple sclerosis]
by: Diego Centonze, et al.
Published: (2016-07-01)

Diagnostic biomarkers of multiple sclerosis
by: Mohammad Asgharzadeh, et al.
Published: (2021-12-01)

Patient and nurse preference for Sensoready autoinjector pen versus other autoinjectors in multiple sclerosis: results from a pilot multicenter survey
by: Amy Perrin Ross, et al.
Published: (2023-02-01)

Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
by: Halil Önder
Published: (2019-06-01)

Autoinjector preference among patients with multiple sclerosis: results from a national survey
by: Limmroth V, et al.
Published: (2017-08-01)

Monitoring the Redox Status in Multiple Sclerosis
by: Masaru Tanaka, et al.
Published: (2020-10-01)

Effectiveness, Healthcare Resource Utilization and Adherence to Subcutaneous Interferon Beta-1a According to Age in Patients With Multiple Sclerosis: A Cohort Study Using a US Claims Database
by: Arthur Allignol, et al.
Published: (2021-07-01)

An updated approach to Multiple Sclerosis
by: Seidy Pedroso-Santana

Association of autoimmune hepatitis and multiple sclerosis: a coincidence?
by: Marta Sofia Mendes Oliveira, et al.
Published: (2015-09-01)

Information Communications Technology-Aided Interactive Space Design Process
by: Burçin Cem Arabacıoğlu, et al.
Published: (2016-06-01)

Progress in the Application of Drugs for the Treatment of Multiple Sclerosis
by: Weipeng Wei, et al.
Published: (2021-07-01)

Update on multiple sclerosis treatments
by: Claire Bridel, et al.
Published: (2014-09-01)

Neuropsychiatric symptoms of multiple sclerosis: A case report
by: P. Espada Dos Santos, et al.
Published: (2021-04-01)

Real-state of autophagy signaling pathway in neurodegenerative disease; focus on multiple sclerosis
by: Mehdi Hassanpour, et al.
Published: (2020-02-01)

Disease-modifying agents in multiple sclerosis
by: Coyle P
Published: (2009-01-01)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
by: Masoud Mohammad Malekzadeh, et al.
Published: (2020-06-01)

Interferon-Beta-Induced Headache in Patients with Multiple Sclerosis: Frequency and Characterization
by: Elmazny A, et al.
Published: (2020-03-01)

Coupling-inspired metasurfaces for polarization-correlation customizable absorption
by: Yongfeng Li, et al.
Published: (2021-01-01)

Effect of interferon beta-1a subcutaneously three times weekly on clinical and radiological measures and no evidence of disease activity status in patients with relapsing–remitting multiple sclerosis at year 1
by: Anthony Traboulsee, et al.
Published: (2018-09-01)

Design and Demonstration of a Low-Cost Small-Scale Fatigue Testing Machine for Multi-Purpose Testing of Materials, Sensors and Structures
by: Jack McAlorum, et al.
Published: (2018-07-01)

Adherence to interferon β treatment in Kosovan multiple sclerosis registry
by: Blerim Myftiu, et al.
Published: (2024-01-01)

Peripheral Vasculitis, Intermediate Uveitis and Interferon Use in Multiple Sclerosis
by: Haluk Esgin
Published: (2016-01-01)